European Partnership on Personalised Medicine
The European Partnership on Personalised Medicine (HORIZON-HLTH-2023-CARE-08-01) is a key initiative under Horizon Europe, designed to accelerate the development and widespread adoption of innovative personalised medicine approaches across Europe and internationally. It fosters collaborative research, translates cutting-edge knowledge into practical clinical applications, and strengthens healthcare systems by integrating innovative biomedical and technological solutions. This program aims to significantly improve patient outcomes and ensure the provision of sustainable, high-quality, and people-centred healthcare for all citizens.
Who is Funded
This section outlines the general eligibility for funding under the European Partnership on Personalised Medicine, detailing the target groups, geographic reach, and the overarching objectives of the program to advance healthcare.
What is Funded
This section provides detailed insights into the types of projects, thematic areas, and activities eligible for funding, alongside information on covered costs and the typical development stages of supported initiatives.
Type and Scope of Funding
This section specifies the financial support mechanisms available, including the type of instruments, funding amounts, and project duration, providing clarity on the financial parameters of the program.
Conditions and Requirements
This section outlines the essential rules and specific conditions that applicants and beneficiaries must adhere to, covering application terms, collaboration rules, and financial stipulations.
Application Procedure
This section guides applicants through the process of submitting proposals, from preparation and documentation to the evaluation and decision-making mechanisms.
Legal Basis
This section details the foundational legal and official documents that authorize and govern the European Partnership on Personalised Medicine, providing insight into its legitimacy and operational framework.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
30% of eligible costs. Financial support to third parties is capped at 10.000.000 €.
Allocated Budget:
100.000.000 €
Award Channel:
Framework Programme Call
Region:
All European Union Member States, countries associated with Horizon Europe, and the United States of America. The program also targets strengthening local and regional ecosystems within these participating geographies.
Sectors:
Healthcare, Medical Technology, Research and Development, Information and Communication Technology, Pharmaceutical Industry, Environmental and Climate Protection
Beneficiaries:
Healthcare
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Pilot Testing, Implementation, Commercialization, Capacity Building, Awareness Campaigns
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Additional Partners:
International Consortium of Personalised Medicine (ICPerMed), European Research Area Network for Personalised Medicine (ERA-PerMed), European Commission (EC) Coordination and Support Actions (CSAs) under Horizon 2020, one million genomes initiative. Synergies are also sought with EU4Health, DEP, ESF+, ERDF, InvestEU, RRF, and TSI programs.
Website: